Antihypertensive drug prescription trends for pregnant women with hypertension in acute hospitals in Japan

Hypertens Res. 2022 Sep;45(9):1441-1446. doi: 10.1038/s41440-022-00956-7. Epub 2022 Jun 17.

Abstract

Hypertensive disorders of pregnancy cause maternal organ damage. Therefore, appropriate management with antihypertensive medication is required from the first trimester. We aimed to clarify the antihypertensive drug prescription trends in pregnant women with hypertension in Japan. The administrative data of pregnant outpatients aged 16-49 years who visited acute hospitals between 2013 and 2020 were included. The annual antihypertensive drug prescription trends were evaluated based on their prescription proportions. The most prescribed drug in 2020 was nifedipine, followed by methyldopa and amlodipine. The proportion of nifedipine prescriptions significantly increased from 33.5 to 40.8% during the study period, whereas that of methyldopa significantly decreased from 16.6 to 11.6%. There was no change in the prescription trend of amlodipine. Dihydropyridine calcium channel blockers were the most commonly prescribed drug for pregnant women with hypertension.

Keywords: Administrative database; Antihypertensive drug; Pregnant women; Prescription; The Japanese Society of Hypertension (JSH) guidelines.

MeSH terms

  • Amlodipine / therapeutic use
  • Antihypertensive Agents* / therapeutic use
  • Calcium Channel Blockers / therapeutic use
  • Drug Prescriptions
  • Female
  • Hospitals
  • Humans
  • Hypertension* / drug therapy
  • Japan
  • Methyldopa / therapeutic use
  • Nifedipine
  • Pregnancy
  • Pregnant Women

Substances

  • Antihypertensive Agents
  • Calcium Channel Blockers
  • Amlodipine
  • Methyldopa
  • Nifedipine